<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5507922</article-id><article-id pub-id-type="publisher-id">5422</article-id><article-id pub-id-type="doi">10.1038/s41598-017-05422-w</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Deficient Vitamin E Uptake During Development Impairs Neural Tube Closure in Mice Lacking Lipoprotein Receptor SR-BI</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8919-833X</contrib-id><name><surname>Santander</surname><given-names>Nicol&#x000e1;s</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Lizama</surname><given-names>Carlos</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Parga</surname><given-names>Mar&#x000ed;a Jos&#x000e9;</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Quiroz</surname><given-names>Alonso</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>P&#x000e9;rez</surname><given-names>Druso</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Echeverr&#x000ed;a</surname><given-names>Guadalupe</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Ulloa</surname><given-names>Lorena</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Palma</surname><given-names>Ver&#x000f3;nica</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Rigotti</surname><given-names>Attilio</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Busso</surname><given-names>Dolores</given-names></name><address><email>dbusso@med.puc.cl</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2157 0406</institution-id><institution-id institution-id-type="GRID">grid.7870.8</institution-id><institution>Department of Nutrition, Diabetes and Metabolism, School of Medicine, </institution><institution>Pontificia Universidad Cat&#x000f3;lica de Chile, </institution></institution-wrap>Santiago, Chile </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2157 0406</institution-id><institution-id institution-id-type="GRID">grid.7870.8</institution-id><institution>Center of Molecular Nutrition and Chronic Diseases, </institution><institution>School of Medicine, Pontificia Universidad Cat&#x000f3;lica de Chile, </institution></institution-wrap>Santiago, Chile </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2297 6811</institution-id><institution-id institution-id-type="GRID">grid.266102.1</institution-id><institution>Cardiovascular Research Institute, </institution><institution>University of California, </institution></institution-wrap>San Francisco, California USA </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0385 4466</institution-id><institution-id institution-id-type="GRID">grid.443909.3</institution-id><institution>Laboratory of Stem Cell and Developmental Biology, </institution><institution>Faculty of Sciences, Universidad de Chile, </institution></institution-wrap>Santiago, Chile </aff></contrib-group><pub-date pub-type="epub"><day>12</day><month>7</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>12</day><month>7</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>7</volume><elocation-id>5182</elocation-id><history><date date-type="received"><day>19</day><month>12</month><year>2016</year></date><date date-type="accepted"><day>30</day><month>5</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">SR-BI is the main receptor for high density lipoproteins (HDL) and mediates the bidirectional transport of lipids, such as cholesterol and vitamin E, between these particles and cells. During early development, SR-BI is expressed in extraembryonic tissue, specifically in trophoblast giant cells in the parietal yolk sac. We previously showed that approximately 50% of SR-BI<sup>&#x02212;/&#x02212;</sup> embryos fail to close the anterior neural tube and develop exencephaly, a perinatal lethal condition. Here, we evaluated the role of SR-BI in embryonic vitamin E uptake during murine neural tube closure. Our results showed that SR-BI<sup>&#x02212;/&#x02212;</sup> embryos had a very low vitamin E content in comparison to SR-BI<sup>+/+</sup> embryos. Whereas SR-BI<sup>&#x02212;/&#x02212;</sup> embryos with closed neural tubes (nSR-BI<sup>&#x02212;/&#x02212;</sup>) had high levels of reactive oxygen species (ROS), intermediate ROS levels between SR-BI<sup>+/+</sup> and nSR-BI<sup>&#x02212;/&#x02212;</sup> embryos were detected in SR-BI<sup>&#x02212;/&#x02212;</sup> with NTD (NTD SR-BI<sup>&#x02212;/&#x02212;</sup>). Reduced expression of Pax3, Alx1 and Alx3 genes was found in NTD SR-BI<sup>&#x02212;/&#x02212;</sup> embryos. Maternal &#x003b1;-tocopherol dietary supplementation prevented NTD almost completely (from 54% to 2%, p&#x02009;&#x0003c;&#x02009;0.001) in SR-BI<sup>&#x02212;/&#x02212;</sup> embryos and normalized ROS and gene expression levels. In sum, our results suggest the involvement of SR-BI in the maternal provision of embryonic vitamin E to the mouse embryo during neural tube closure.</p></abstract><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Scavenger Receptor Class B type I (SR-BI) is the main receptor for high density lipoproteins (HDL), and numerous studies have described its role in mediating the bidirectional transport of lipids between these lipoproteins and cells<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. In the liver, SR-BI is involved in the uptake of cholesterol from HDL and its excretion in bile, the final step in reverse cholesterol transport. SR-BI also participates in the uptake of cholesterol in steroidogenic tissues, such as the adrenal glands and ovaries, to be used as a substrate for steroid hormone synthesis<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. Important information on the roles of SR-BI other than in cholesterol homeostasis and cholesterol provision for steroidogenesis, such as platelet aggregation, erythrocyte maturation and oocyte meiosis, has been generated from the SR-BI knock out (SR-BI<sup>&#x02212;/&#x02212;</sup>) mouse since it was generated almost two decades ago<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>.</p><p id="Par3">In generating SR-BI<sup>&#x02212;/&#x02212;</sup> mice via heterozygous intercrosses, researchers noted that the proportion of weaned homozygous null mice was half that expected by the Mendelian ratio<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. This evidence, together with the fact that SR-BI is present in murine trophoblasts involved in maternal-foetal nutrient exchange at different stages of gestation<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>, led researchers to postulate that this HDL receptor might be involved in embryonic development. We recently showed that nearly 50% of SR-BI<sup>&#x02212;/&#x02212;</sup> embryos fail to close the anterior neural tube and develop cranial NTD and exencephaly<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>, leading to perinatal death, which explains the deviation from the Mendelian ratio previously reported in weaned SR-BI null mice<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. Among the spectrum of defective neurulation conditions conferred by abnormal closure at different portions of the neural tube, only cranial NTD is observed in SR-BI<sup>&#x02212;/&#x02212;</sup> embryos.</p><p id="Par4">During murine early development, SR-BI is not detected in the embryo itself but rather in trophoblast giant cells (TGC) from the parietal yolk sac<sup><xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref></sup>. TGC play a critical role in embryonic uptake of various nutrients from the maternal blood supply before the establishment of a mature placenta<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. Despite the prominent role of SR-BI in cholesterol uptake<sup><xref ref-type="bibr" rid="CR1">1</xref></sup> and the key role of cholesterol during embryonic development<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>, we have shown that the embryonic cholesterol content is similar in SR-BI<sup>+/+</sup> and SR-BI<sup>&#x02212;/&#x02212;</sup> embryos<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>.</p><p id="Par5">In addition to cholesterol, HDL particles also transport other lipids, such as triglycerides, lipophilic vitamins and hydrophobic signalling molecules. Studies using adult SR-BI<sup>&#x02212;/&#x02212;</sup> mice demonstrated lower levels of vitamin E in several SR-BI-expressing tissues, suggesting that beyond its role as a cholesterol transporter, this receptor also mediates the cellular uptake of vitamin E from HDL<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. Vitamin E is a generic name for a group of isomers of two related molecules: tocopherols and tocotrienols. This vitamin was first described almost 100 years ago to be an essential factor for the success of pregnancy in rats<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. Vitamin E isomers have antioxidant activity and intercalate between lipids in biological membranes, where they stop reactive oxygen species (ROS)-based reactions that generate lipoperoxides<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. In addition, some isomers have other less well-defined biological activities, such as modulation of intracellular signalling pathways, gene expression and cell proliferation<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. Vitamin E deficiency in rodents has been associated with congenital malformations, including neural tube defects (NTD)<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. Consistent with this finding, this vitamin is effective in preventing NTD in mouse models of maternal diabetes-induced malformations, which are associated with an increased oxidative status<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>.</p><p id="Par6">Considering this evidence, we hypothesized that NTD in SR-BI<sup>&#x02212;/&#x02212;</sup> embryos was due to oxidative stress resulting from impaired vitamin E uptake from maternal circulation. To test this hypothesis, we studied the incidence of NTD, vitamin E content, ROS levels and gene expression in embryos and in TGC retrieved from dams fed with control or &#x003b1;-tocopherol-enriched diets.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>Effect of maternal &#x003b1;-tocopherol supplementation on NTD in SR-BI<sup>&#x02212;/&#x02212;</sup> embryos</title><p id="Par7">As a first approach to determine if defective maternal-embryonic vitamin E metabolism contributes to neural malformation in SR-BI<sup>&#x02212;/&#x02212;</sup> embryos, we sought to analyse whether &#x003b1;-tocopherol supplementation in pregnant SR-BI<sup>+/&#x02212;</sup> dams reduced the incidence of NTD. The rationale behind this hypothesis was that if SR-BI is involved in vitamin E transport across the maternal foetal interface, then increasing the concentration of this vitamin in the maternal plasma may compensate for the lack of SR-BI via SR-BI-independent transport pathways. This possibility was strongly supported by our analysis of transcriptomic data in parietal TGC generated by Hannibal <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR14">14</xref></sup> which showed that, besides SR-BI, TGC express other proteins that are involved in lipoprotein metabolism, such as the HDL receptor Gpihbp1, receptors for others lipoproteins (e.g., Ldlr, Apobr, and Lrp1), and the lipid transporters Abca1 and Abcg1, which mediate lipid efflux from cells to Apoa1 and HDL, respectively (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Gene expression analysis<sup><italic>#</italic></sup> of lipoprotein receptors and lipid transporters in trophoplast giant cells.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="3"/><th colspan="2">Read count</th></tr><tr><th>Group</th><th>Gene</th><th>Alternative name</th><th>mean</th><th>SD</th></tr></thead><tbody><tr><td rowspan="3">Positive Controls</td><td>Prl3d1</td><td>Pl-1</td><td>170429</td><td>66683</td></tr><tr><td>Prl3b1</td><td>Pl-2</td><td>495</td><td>196</td></tr><tr><td>Prl2c2</td><td>Plf</td><td>466</td><td>219</td></tr><tr><td rowspan="2">Negative Controls</td><td>Tpbpa</td><td/><td>32</td><td>13</td></tr><tr><td>Ctsq</td><td/><td>3</td><td>2</td></tr><tr><td rowspan="3">HDL Receptors</td><td>Scarb1</td><td>SR-BI</td><td>20331</td><td>7680</td></tr><tr><td>Atp5b</td><td/><td>1578</td><td>617</td></tr><tr><td>Gpihbp1</td><td/><td>444</td><td>261</td></tr><tr><td rowspan="4">LDL Receptors</td><td>Ldlr</td><td/><td>1416</td><td>538</td></tr><tr><td>Apobr</td><td/><td>574</td><td>190</td></tr><tr><td>Olr1</td><td>LOX-1</td><td>555</td><td>239</td></tr><tr><td>Lrp10</td><td/><td>551</td><td>208</td></tr><tr><td>Chilomicrons Receptors</td><td>Lrp1</td><td/><td>187</td><td>84</td></tr><tr><td rowspan="2">Lipid Transporters</td><td>Abca1</td><td/><td>142</td><td>61</td></tr><tr><td>Abcg1</td><td/><td>124</td><td>48</td></tr></tbody></table><table-wrap-foot><p>
<sup>#</sup>Analysis of data generated by Hannibal, <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>.</p></table-wrap-foot></table-wrap>
</p><p id="Par8">Because vitamin E supplementation has been shown to reduce plasma cholesterol levels in rodent models of hypercholesterolemia<sup><xref ref-type="bibr" rid="CR15">15</xref>&#x02013;<xref ref-type="bibr" rid="CR17">17</xref></sup> and because cholesterol has been shown to be crucial for embryonic development<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>, we analysed the impact of &#x003b1;-tocopherol supplementation on the plasma cholesterol levels of pregnant dams. Consumption of the vitamin-enriched diet did not affect the total circulating cholesterol levels nor its distribution into lipoproteins, as both parameters were similar in dams fed control or supplemented diets (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">1a and b</xref>). Alpha-tocopherol dietary supplementation from conception until gestational day 9.5 (E9.5) resulted in a significant rise in this lipid in maternal plasma (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>). Interestingly, the vitamin E distribution in lipoproteins was affected by &#x003b1;-tocopherol supplementation. Compared to plasma from control mice, in which almost no &#x003b1;-tocopherol was detected in larger lipoproteins such as LDL, VLDL or chylomicrons, plasma from dams fed the vitamin E-enriched diet exhibited similar levels of &#x003b1;-tocopherol in HDL and non-HDL particles (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b</xref>). In sum, the expression of other lipoprotein receptors than SR-BI in TGC (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>) and the detection of &#x003b1;-tocopherol in non-HDL lipoproteins in SR-BI<sup>+/&#x02212;</sup> dams fed the vitamin E-supplemented diet (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b</xref>) suggest the co-existence of different &#x003b1;-tocopherol transport mechanisms from maternal blood into TGC, involving both HDL and non-HDL lipoproteins.<fig id="Fig1"><label>Figure 1</label><caption><p>Plasmatic total (<bold>a</bold>) and lipoprotein (<bold>b</bold>) &#x003b1;-tocopherol levels in SR-BI<sup>+/&#x02212;</sup> pregnant dams fed with control or vitamin E supplemented diets. Concentrations of &#x003b1;-tocopherol in total plasma (<bold>a</bold>) or in different lipoproteins (<bold>b</bold>). VLDL/ChM: fraction containing very low density lipoproteins and chylomicrons. LDL: low density lipoproteins. HDL: high density lipoproteins. The horizontal lines indicate median (<bold>a</bold>) and mean (<bold>b</bold>). *p&#x02009;&#x0003c;&#x02009;0.05, assessed by Mann-Whitney (<bold>a</bold>) or two-way ANOVA with Holms-Sidak post-test (<bold>b</bold>).</p></caption><graphic xlink:href="41598_2017_5422_Fig1_HTML" id="d29e781"/></fig>
</p><p id="Par9">To analyse the impact of &#x003b1;-tocopherol supplementation on the incidence of NTD, embryos at E9.5 were retrieved from chow- or vitamin E-fed heterozygous dams and phenotypically classified as normal or as having NTD. Consistent with previous results from our group, a significant proportion of SR-BI<sup>&#x02212;/&#x02212;</sup> embryos (54%) and a few SR-BI<sup>&#x02212;/+</sup> embryos (6%) from chow-fed SR-BI<sup>&#x02212;/+</sup> dams exhibited cranial NTD (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). By contrast, only 1 out of 59 SR-BI<sup>&#x02212;/&#x02212;</sup> embryos and 2 out of 129 SR-BI<sup>&#x02212;/+</sup> embryos (less than 2% in both cases) showed cranial NTD in vitamin E-supplemented SR-BI<sup>&#x02212;/+</sup> pregnancies (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Interestingly, &#x003b1;-tocopherol supplementation after implantation, starting from E4.5, also reduced the proportion of SR-BI<sup>&#x02212;/&#x02212;</sup> and SR-BI<sup>&#x02212;/+</sup> embryos with NTD to levels comparable with supplementation from E0.5 to E9.5 (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). Injecting pregnant dams with folic acid, a water-soluble vitamin that is well known to prevent NTD, reduced the percentage of SR-BI<sup>&#x02212;/&#x02212;</sup> embryos with NTD from 56% to 19%, showing that NTD is folate-sensitive in SR-BI<sup>&#x02212;/&#x02212;</sup> embryos (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). The mean number of viable embryos that showed cardiac activity and the mean number of resorptions retrieved per dam were similar in the control, vitamin E- and folate-supplemented groups, indicating that embryonic viability and female fertility were not affected by these maternal interventions (Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">2</xref>). As in our previous work, only cranial NTD, and not defective closure in the dorsal or posterior neural tube, was observed in SR-BI<sup>&#x02212;/&#x02212;</sup> and SR-BI<sup>&#x02212;/+</sup> embryos, irrespective of treatment. In summary, &#x003b1;-tocopherol dietary supplementation, starting either after mating or at implantation, proved to be a highly efficient intervention to prevent NTD in SR-BI-deficient embryos.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Incidence of NTD in SR-BI<sup>+/&#x02212;</sup> and SR-BI<sup>&#x02212;/&#x02212;</sup> embryos obtained from SR-BI<sup>+/&#x02212;</sup> dams fed chow or vitamin E-supplemented diets from E0.5 to E9.5.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Treatment</th><th colspan="3">SR-BI<sup>+/+</sup> no. (%)</th><th colspan="3">SR-BI<sup>+/&#x02212;</sup> no. (%)</th><th colspan="3">SR-BI<sup>&#x02212;/&#x02212;</sup> no. (%)</th></tr><tr><th>Normal</th><th>NTD</th><th>Total</th><th>Normal</th><th>NTD</th><th>Total</th><th>Normal</th><th>NTD</th><th>Total</th></tr></thead><tbody><tr><td>Control</td><td>70 (100%)</td><td>0 (0%)</td><td>70</td><td>163 (94%)</td><td>10 (6%)</td><td>173</td><td>34 (46%)</td><td>40 (54%)</td><td>74</td></tr><tr><td>Vitamin E</td><td>49 (100%)</td><td>0 (0%)</td><td>49</td><td>127 (98%)</td><td>2 (2%)</td><td>129</td><td>58 (98%)</td><td>1 (2%)<sup>a</sup>
</td><td>59</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>p&#x02009;&#x0003c;&#x02009;0.001 vs. Control; Fisher&#x02019;s exact test.</p></table-wrap-foot></table-wrap>
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Incidence of NTD in SR-BI<sup>&#x02212;/&#x02212;</sup> embryos from SR-BI<sup>+/&#x02212;</sup> dams fed chow or vitamin E-supplemented diets starting from conception (E0.5) or from implantation (E4.5) until E9.5.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Treatment</th><th colspan="3">SR-BI<sup>+/+</sup> no. (%)</th><th colspan="3">SR-BI<sup>+/&#x02212;</sup> no. (%)</th><th colspan="3">SR-BI<sup>&#x02212;/&#x02212;</sup> n&#x000b0; (%)</th></tr><tr><th>Normal</th><th>NTD</th><th>Total</th><th>Normal</th><th>NTD</th><th>Total</th><th>Normal</th><th>NTD</th><th>Total</th></tr></thead><tbody><tr><td>Control</td><td>9 (90%)</td><td>1 (10%)</td><td>10</td><td>26 (90%)</td><td>3 (10%)</td><td>29</td><td>7 (50%)</td><td>7 (50%)</td><td>14</td></tr><tr><td>Vitamin E</td><td>21 (100%)</td><td>0 (0%)</td><td>21</td><td>33 (100%)</td><td>0 (0%)</td><td>33</td><td>12 (92%)</td><td>1 (8%)<sup>a</sup>
</td><td>13</td></tr><tr><td>Vitamin E 4&#x02013;9</td><td>15 (94%)</td><td>1 (6%)</td><td>16</td><td>26 (96%)</td><td>1 (4%)</td><td>27</td><td>13 (93%)</td><td>1 (7%)<sup>a</sup>
</td><td>14</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>p&#x02009;&#x0003c;&#x02009;0.05 vs. Control; Fisher&#x02019;s exact test.</p></table-wrap-foot></table-wrap>
<table-wrap id="Tab4"><label>Table 4</label><caption><p>Incidence of NTD in SR-BI<sup>&#x02212;/&#x02212;</sup> embryos from SR-BI<sup>+/&#x02212;</sup> dams injected with folic acid or vehicle.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Treatment</th><th colspan="3">SR-BI<sup>+/+</sup> no. (%)</th><th colspan="3">SR-BI<sup>+/&#x02212;</sup> no. (%)</th><th colspan="3">SR-BI<sup>&#x02212;/&#x02212;</sup> no. (%)</th></tr><tr><th>Normal</th><th>NTD</th><th>Total</th><th>Normal</th><th>NTD</th><th>Total</th><th>Normal</th><th>NTD</th><th>Total</th></tr></thead><tbody><tr><td>Control</td><td>27 (100%)</td><td>0 (0%)</td><td>27</td><td>58 (97%)</td><td>2 (3%)</td><td>60</td><td>12 (44%)</td><td>15 (56%)</td><td>27</td></tr><tr><td>Folate</td><td>29 (94%)</td><td>2 (6%)</td><td>31</td><td>85 (96%)</td><td>4 (4%)</td><td>89</td><td>30 (81%)</td><td>7 (19%)<sup>a</sup>
</td><td>37</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>p&#x02009;=&#x02009;0.05 vs. Control; Fisher&#x02019;s exact test.</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec4"><title>Vitamin E content in embryos and parietal yolk sacs lacking SR-BI</title><p id="Par10">We next sought to determine whether the lack of SR-BI affected the vitamin E content in SR-BI<sup>&#x02212;/&#x02212;</sup> mouse embryos and TGC, as previously reported for certain adult tissues<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. Supporting the notion that SR-BI is involved in vitamin E maternal-embryonic provision, &#x003b1;-tocopherol quantification in SR-BI<sup>&#x02212;/&#x02212;</sup> embryos showed a 50-fold reduction compared to SR-BI<sup>+/+</sup> embryos (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2a</xref>). Two unexpected results were obtained from these experiments: i) the very low vitamin E content was similar in SR-BI<sup>&#x02212;/&#x02212;</sup> embryos with NTD (SR-BI<sup>&#x02212;/&#x02212;</sup> NTD) or with normal neural tube closure (nSR-BI<sup>&#x02212;/&#x02212;</sup>) and ii) maternal supplementation with &#x003b1;-tocopherol did not increase the embryonic vitamin E levels, despite its striking effect on NTD prevention (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2a</xref>).<fig id="Fig2"><label>Figure 2</label><caption><p>Vitamin E content in embryos (<bold>a</bold>) and parietal yolk sac (PYS) (<bold>b</bold>) obtained from SR-BI<sup>+/&#x02212;</sup> dams fed with control or vitamin E supplemented diets. Levels of &#x003b1;-tocopherol were measured in pairs of wild-type embryos (SR-BI<sup>+/+</sup>), normal knock-out embryos (nSR-BI<sup>&#x02212;/&#x02212;</sup>) and knock-out embryos with NTD (SR-BI<sup>&#x02212;/&#x02212;</sup> NTD) (<bold>a</bold>) and in single PYS (<bold>b</bold>). **p&#x02009;&#x02264;&#x02009;0.01, ***p&#x02009;&#x02264;&#x02009;0.001, determined by one-way ANOVA and Tukey&#x02019;s post-test.</p></caption><graphic xlink:href="41598_2017_5422_Fig2_HTML" id="d29e1390"/></fig>
</p><p id="Par11">SR-BI is specifically expressed in TGC, but these large cells are tightly adhered to small parietal endoderm cells by a thick extracellular matrix constituting the parietal yolk sac (PYS). In order to avoid potential modifications in the metabolic or transcriptional status of TGCs due to isolation procedures, we determined the content of &#x003b1;-tocopherol in the PYS as a whole. The &#x003b1;-tocopherol content was similar in PYS from SR-BI<sup>+/+</sup> and SR-BI<sup>&#x02212;/&#x02212;</sup> embryos with or without NTD obtained from chow-fed dams (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2b</xref>). Although maternal supplementation with &#x003b1;-tocopherol did not increase the vitamin E content in SR-BI<sup>+/+</sup> PYS, the vitamin E content was almost 5-fold higher in SR-BI<sup>&#x02212;/&#x02212;</sup> PYS.</p></sec><sec id="Sec5"><title>Redox status in SR-BI<sup>&#x02212;/&#x02212;</sup> embryos and TGC</title><p id="Par12">Because accumulation of oxidative species has been shown to impair neural tube closure in mice<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>, we determined the reactive oxygen species (ROS) levels by fluorimetry in vitamin E-deficient SR-BI<sup>&#x02212;/&#x02212;</sup> embryos (see methods and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2</xref>). In chow-fed dams, nSR-BI<sup>&#x02212;/&#x02212;</sup> embryos exhibited a 5-fold higher fluorescence intensity compared to SR-BI<sup>+/+</sup> embryos (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a</xref>). Surprisingly, NTD SR-BI<sup>&#x02212;/&#x02212;</sup> embryos showed intermediate fluorescence levels compared to SR-BI<sup>+/+</sup> and nSR-BI<sup>&#x02212;/&#x02212;</sup>. Maternal &#x003b1;-tocopherol supplementation resulted in significantly lower ROS levels in SR-BI<sup>&#x02212;/&#x02212;</sup> embryos, similar to the fluorescence levels in SR-BI<sup>+/+</sup> embryos. Trophoblast giant cells have been shown to produce significant ROS due to high activity of the enzyme NADPH oxidase<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. However, SR-BI deficiency did not affect ROS levels in parietal yolk sacs from embryos obtained from mothers fed control or vitamin E-enriched diets (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3b</xref>). Together, these results show that excess ROS in SR-BI<sup>&#x02212;/&#x02212;</sup> embryos can be prevented by maternal &#x003b1;-tocopherol supplementation.<fig id="Fig3"><label>Figure 3</label><caption><p>ROS index in embryos (<bold>a</bold>) and parietal yolk sac (PYS) (<bold>b</bold>) obtained from SR-BI<sup>+/&#x02212;</sup> dams fed with control or vitamin E supplemented diets. Levels of reactive oxygen species were measured using DCF-DA in pairs of wild-type embryos (SR-BI<sup>+/+</sup>), normal knock-out embryos (nSR-BI<sup>&#x02212;/&#x02212;</sup>) and knock-out embryos with NTD (SR-BI<sup>&#x02212;/&#x02212;</sup> NTD) (<bold>a</bold>) and single PYS (<bold>b</bold>). *p&#x02009;&#x02264;&#x02009;0.05, **p&#x02009;&#x02264;&#x02009;0.01, determined by one-way ANOVA and Tukey&#x02019;s post-test.</p></caption><graphic xlink:href="41598_2017_5422_Fig3_HTML" id="d29e1496"/></fig>
</p><p id="Par13">High ROS production and oxidative stress are associated with an antioxidant response that is characterized by up-regulation of the expression of several enzymes that metabolize ROS into harmless compounds. Using real time PCR, we compared the expression of genes encoding antioxidant enzymes in SR-BI<sup>+/+</sup> and SR-BI<sup>&#x02212;/&#x02212;</sup> embryos (with or without NTD) as well as in their respective PYS, from dams fed chow or vitamin E-enriched diets. Our results showed similar expression of <italic>Gsr</italic>, <italic>Cat</italic>, <italic>Sod2</italic>, <italic>Txn2</italic> and <italic>Glrx</italic> among embryos of different genotypes, phenotypes or maternal diets (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). We also evaluated the expression of <italic>Ppargc1a</italic>, a target and master regulator of the antioxidant response<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>, and found that its expression was also similar among the embryos from different groups (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). In PYS, minor changes with unclear biological significance were found in <italic>Cat</italic>, <italic>Txn2</italic> and <italic>Glrx</italic> gene expression (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">3</xref>), independent of genotype, phenotype, or dietary treatment. We did not compare the expression of <italic>Ppargc1a</italic> in PYS because the mRNA levels were below the detection limit in this tissue.<fig id="Fig4"><label>Figure 4</label><caption><p>Antioxidant gene expression response in embryos obtained from SR-BI<sup>+/&#x02212;</sup> dams fed with control or vitamin E supplemented diets. Expression levels of genes activated during antioxidant response were measured in pools of 3 wild-type embryos (SR-BI<sup>+/+</sup>), normal knock-out embryos (nSR-BI<sup>&#x02212;/&#x02212;</sup>) and knock-out embryos with NTD (SR-BI<sup>&#x02212;/&#x02212;</sup> NTD). N&#x02009;=&#x02009;3 pools per group.</p></caption><graphic xlink:href="41598_2017_5422_Fig4_HTML" id="d29e1571"/></fig>
</p></sec><sec id="Sec6"><title>Expression of genes involved in neural tube closure in SR-BI<sup>&#x02212;/&#x02212;</sup> embryos</title><p id="Par14">As gene expression orchestrates the molecular and cellular processes that take place during neural tube closure, many mutations in mouse genes coding for transcription factors give rise to NTD<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. Thus, we tested whether abnormal gene expression contributed to NTD in SR-BI<sup>&#x02212;/&#x02212;</sup> embryos and whether this expression was normalized after maternal &#x003b1;-tocopherol supplementation. We compared the mRNA levels for genes known to be relevant for neural tube closure in SR-BI<sup>+/+</sup> and SR-BI<sup>&#x02212;/&#x02212;</sup> embryos of both phenotypes (normal or NTD) obtained from control chow- or vitamin E-fed dams. We first analysed the expression of genes coding for proteins involved in the Hedgehog (Hh) signalling pathway, one of the main regulators of neural tube closure and neuronal specification<sup><xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref></sup>. We observed similar expression for Hh gene targets in SR-BI<sup>&#x02212;/&#x02212;</sup> embryos compared to SR-BI<sup>+/+</sup> embryos (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">4</xref>). We also checked the mRNA levels for <italic>Pax3</italic>, a key paired-box transcription factor whose inactivation leads to NTD with total penetrance in the Splotch mouse<sup><xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref></sup>. <italic>Pax3</italic> expression is significantly reduced in murine models of maternal diabetes, in association with an embryonic accumulation of ROS and a partially penetrant NTD phenotype<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. Our results showed altered <italic>Pax3</italic> expression, specifically in NTD SR-BI<sup>&#x02212;/&#x02212;</sup> embryos from chow-fed dams compared to nSR-BI<sup>&#x02212;/&#x02212;</sup> (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5a</xref>). We also examined gene expression of two members of the aristaless-like (Alx) homeobox protein family that are involved in neural tube closure. One of these genes is <italic>Alx3</italic>, whose inactivation induces a partially penetrant NTD phenotype<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. Interestingly, reduction in <italic>Alx3</italic> expression is observed in mouse embryos deficient for Lrp2, a multiligand receptor mediating HDL endocytosis<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. Our results showed that expression of <italic>Alx3</italic> was significantly reduced in NTD SR-BI<sup>&#x02212;/&#x02212;</sup> embryos compared to SR-BI<sup>+/+</sup> embryos and to nSR-BI<sup>&#x02212;/&#x02212;</sup> embryos (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5b</xref>). Maternal treatment with vitamin E normalized <italic>Alx3</italic> expression in SR-BI<sup>&#x02212;/&#x02212;</sup> embryos. Another member of the aristaless-like family of proteins that is involved in neural tube closure is <italic>Alx1</italic>
<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>, which has an expression domain and function that are partly redundant with <italic>Alx3</italic>
<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. <italic>Alx1</italic> expression in NTD SR-BI<sup>&#x02212;/&#x02212;</sup> embryos was 8-fold lower than that in nSR-BI<sup>&#x02212;/&#x02212;</sup> embryos (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5b</xref>). Regardless of genotype, embryos from vitamin E-supplemented dams had higher <italic>Alx1</italic> expression than embryos from chow-fed dams.<fig id="Fig5"><label>Figure 5</label><caption><p>Expression of neural tube closure-related transcription factors in embryos obtained from SR-BI<sup>+/&#x02212;</sup> dams fed with control or vitamin E supplemented diets. Expression levels of Pax3 (<bold>a</bold>) and Alx transcription factors (<bold>b</bold>) were determined in pools of 3 E9.5 wild-type embryos (SR-BI<sup>+/+</sup>), normal knock-out embryos (nSR-BI<sup>&#x02212;/&#x02212;</sup>) and knock-out embryos with NTD (SR-BI<sup>&#x02212;/&#x02212;</sup> NTD). N&#x02009;=&#x02009;3 pools per group.</p></caption><graphic xlink:href="41598_2017_5422_Fig5_HTML" id="d29e1736"/></fig>
</p></sec></sec><sec id="Sec7" sec-type="discussion"><title>Discussion</title><p id="Par15">Although several lipids have been shown to be crucial for early development, the molecular mechanisms explaining the transport of these molecules between the mother and embryo or foetus are still not completely understood. Early embryonic nutrition is accomplished by the transport of nutrients from maternal endometrial glands to the embryo through TGC and visceral endoderm cells of the yolk sac. Given the expression of SR-BI in TGC and the high incidence of NTD in SR-BI<sup>&#x02212;/&#x02212;</sup> mouse embryos<sup><xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref></sup>, we assessed the role of SR-BI in embryonic vitamin E uptake and its implications for neural tube closure. Our main findings are that SR-BI<sup>&#x02212;/&#x02212;</sup> embryos exhibit defective embryonic vitamin E levels and that maternal &#x003b1;-tocopherol supplementation can almost completely prevent NTD in SR-BI<sup>&#x02212;/&#x02212;</sup> embryos.</p><p id="Par16">In rodents, vitamin E is essential for the success of pregnancy, and maternal deficiency of this vitamin has been associated with NTD in offspring, among other malformations<sup><xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR29">29</xref></sup>. In one study describing embryos lacking the main intracellular &#x003b1;-tocopherol binding protein (Ttpa), researchers suggested that vitamin E is required for placental formation and not essential for embryo development itself<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. Our results support the idea that uptake of this nutrient is required for neural tube closure during early development, even before the establishment of a fully functional placenta.</p><p id="Par17">Impaired lipoprotein metabolism in the maternal-embryonic interface has been previously linked to neural tube closure abnormalities. For example, genetic inactivation of microsomal triglyceride transfer protein (Mttp) impairs lipoprotein packaging in the endoplasmic reticulum of the visceral endoderm and is associated with embryonic lethality and cranial NTD<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. Apob-containing lipoproteins have been shown to be secreted from the visceral endoderm into the embryonic environment<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. In various mouse models with inactivating mutations in the Apob gene, homozygosity leads to embryonic lethality, characterized by the presence of cranial NTD in a subset of the mutants<sup><xref ref-type="bibr" rid="CR33">33</xref>&#x02013;<xref ref-type="bibr" rid="CR35">35</xref></sup>. Interestingly, embryos lacking Apob have slightly lower cholesterol than wild-type embryos and extremely low levels of vitamin E<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>, providing further support to the idea that reduced transport of this vitamin may impair neural tube closure. However, in contrast to SR-BI<sup>&#x02212;/&#x02212;</sup> embryos, maternal vitamin E supplementation of dams that are heterozygous for the Apob mutation does not prevent NTD in homozygous embryos<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. It is possible that the visceral endoderm entirely relies on Apob and Mttp to secrete vitamin E to Apob-containing lipoproteins, rendering maternal supplementation ineffective. By contrast, TGC may rely on other vitamin E transport mechanism besides SR-BI, as suggested by the expression of diverse proteins that are involved in lipoprotein uptake by receptor-mediated endocytosis in extraembryonic tissues. These pathways might be efficient enough to compensate for the lack of SR-BI in SR-BI<sup>&#x02212;/&#x02212;</sup> TGC, providing them with vitamin E after maternal overloading of this nutrient. The redistribution of this vitamin into different classes of lipoproteins in &#x003b1;-tocopherol-supplemented dams further supports this possibility.</p><p id="Par18">An unexpected result was that, despite the high levels of vitamin E in SR-BI<sup>&#x02212;/&#x02212;</sup> TGC and prevention of NTD in SR-BI<sup>&#x02212;/&#x02212;</sup> embryos, embryonic vitamin E levels were not restored by maternal supplementation with &#x003b1;-tocopherol. Among the possibilities that could explain this finding is that vitamin E transported by SR-BI-independent mechanisms may be oxidized or metabolized rapidly before or&#x000a0;during transport to the embryo, becoming undetectable by the methods used. Future experiments involving the detection of vitamin E metabolites in PYS and embryos could aid in testing this hypothesis. Alternatively, there may be an indirect effect on the embryo caused by vitamin E loading of TGC. Although this possibility is not supported by our results, which show similar levels of ROS and mRNA for genes from the antioxidant response in PYS of different genotypes or phenotypes, the use of whole PYS instead of TGCs might have reduced the sensitivity of the assay. In this work, TGCs were not separated from parietal endoderm cells to avoid the potential effects of the isolation procedure on the cellular composition.</p><p id="Par19">Among various genetic and environmental causes of NTD identified in both human and animal experimental studies, nutrient inadequacies are important factors increasing the susceptibility to defective neural tube closure. Over the last few decades, maternal periconceptional supplementation with folic acid has proven to be a safe and efficient intervention to reduce the incidence of human and experimental NTD. However, both folate responsive and folate-resistant NTD have been detected in human and animal embryos, leading researchers to propose the use of combined therapies including folate and other nutrients, such as inositol<sup><xref ref-type="bibr" rid="CR38">38</xref></sup> or multivitamin supplements<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>, to reduce NTD. In this work, our results show that cephalic defective neurulation in SR-BI-deficient embryos can be reduced by supplementing dams with folate or vitamin E. Although we cannot compare the effectiveness of each intervention due to the use of unique doses and different administration routes, our findings of vitamin E deficiency and NTD prevention in SR-BI null embryos support the idea that other nutrients besides folate need to be considered for the prevention of NTD, given the complex and heterogeneous aetiology of this condition.</p><p id="Par20">One of the principles underlying NTD and other congenital malformations in rodents is excessive embryonic oxidative stress, which is observed <italic>in vivo</italic> in rodent models of maternal diabetes<sup><xref ref-type="bibr" rid="CR13">13</xref></sup> and ethanol consumption<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>, and in mice deficient for thioredoxin 2 (Txn2), a protein scavenging ROS in mitochondria<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. Vitamin E has proven to be effective in preventing ROS-induced NTD in murine models both <italic>in vivo</italic>
<sup><xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR42">42</xref></sup> and <italic>in vitro</italic>
<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. In this work, normalization of ROS levels in SR-BI<sup>&#x02212;/&#x02212;</sup> embryos after maternal &#x003b1;-tocopherol supplementation suggests an antioxidant effect of this vitamin E<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. However, we cannot rule out, at present, the existence of additional non-antioxidant effects of &#x003b1;-tocopherol contributing to the results described.</p><p id="Par21">It is worth noting that although all SR-BI<sup>&#x02212;/&#x02212;</sup> embryos had low levels of vitamin E, only approximately half of the embryos exhibited NTD. The incomplete penetrance of NTD in isogenic embryos that developed in a homogeneous uterine environment has been previously observed in mouse models<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. Phenotypic discordance for disease susceptibility has also been shown in monozygotic human twins<sup><xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref></sup>, including twins discordant for anencephaly<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. Studies in <italic>C</italic>. <italic>elegans</italic> have suggested that inter-individual stochastic variations in gene expression and activation of compensatory mechanisms could account for different phenotypic consequences of mutations in those organisms<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>. Similarly, we detected that SR-BI<sup>&#x02212;/&#x02212;</sup> embryos that underwent neural tube closure exhibited higher mRNA levels for a subset of genes involved in neural tube closure compared to SR-BI<sup>&#x02212;/&#x02212;</sup> with NTD, including Pax3 and 2 genes of the aristaless-like family (Alx1 and Alx3). The fact that SR-BI<sup>&#x02212;/&#x02212;</sup> embryos obtained from vitamin E-supplemented dams exhibited similar or even higher expression of those genes than embryos from chow-fed dams suggests that normalization of the expression of those genes might contribute to the prevention of NTD in our model. It cannot be discounted, however, that deficiencies in mRNA levels for those genes may be a consequence and not a cause of failed neurulation.</p><p id="Par22">Despite the involvement of SR-BI in human cholesterol homeostasis and cardiovascular function, no null mutations and very few loss-of-function mutations in the human gene coding for SR-BI have been reported<sup><xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref></sup>. Considering that SR-BI mutations are very rare in humans and that SR-BI is expressed in first trimester human trophoblasts, it could be speculated that null or severely deficient SR-BI gene expression might hinder human embryonic development. In humans, vitamin E supplementation during mid and late pregnancy has proven to be inefficient in preventing stillbirth, neonatal death, preterm birth, pre-eclampsia or poor foetal growth<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. Two retrospective studies have suggested a relationship between maternal vitamin E consumption, estimated through food questionnaires, and offspring NTD<sup><xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref></sup>. In one of the studies, a reduction of the incidence of anencephaly, and not of other NTD, was only observed in the third quartile of vitamin E consumption<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. In the second study, a higher intake of vitamin E and other micronutrients was associated with decreased risk of spina bifida<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>. Although the incidence of NTD in various human populations has been successfully reduced by folic acid consumption, in particular in countries where primary preventive strategies have been implemented<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>, this malformation has not completely been abolished. In this regard, ensuring adequate vitamin E levels by appropriate nutritional counselling for pregnant women could aid in reducing the remaining risk of human NTD. This could be especially beneficial for pregnant women with disorders associated with a higher oxidative status, such as obesity and type 1 and 2 diabetes, all of which exhibit a higher risk for NTD<sup><xref ref-type="bibr" rid="CR54">54</xref>&#x02013;<xref ref-type="bibr" rid="CR56">56</xref></sup>. Short-term vitamin E supplementation, although not free from potential associated risks, could also be envisioned as a potential intervention for women willing to conceive after one or more previously folate-resistant NTD-affected pregnancies.</p></sec><sec id="Sec8" sec-type="materials|methods"><title>Methods</title><sec id="Sec9"><title>RNA-Seq analysis pipeline</title><p id="Par23">We analysed the dataset generated by Hannibal <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>, which was produced by RNA sequencing of polyA<sup>+</sup> RNA from isolated mouse E9.5 parietal TGC. The Single End Reads RNA raw sequence files (.fastq files) were extracted from GEO Accession Number GSE50585. We used the entries GSM1223565, GSM1223566, GSM1223567 and GSM1223568 to generate our data, which underwent quality control analysis using FastQC (<ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/fastqc/">http://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link>). Single End RNAseq reads were groomed using FASTQ groomer V1.04<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>, and groomed reads were mapped to the mouse genome (mm10) using TopHat2 version 0.7<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>. Aligned reads were counted using HTseq-count Version 1.0.0<sup><xref ref-type="bibr" rid="CR59">59</xref></sup> to generate a digital expression matrix. To ensure that all of the sequences were processed consistently, all of the above steps were performed as part of a Galaxy workflow, which can be found at <ext-link ext-link-type="uri" xlink:href="https://usegalaxy.org/u/laiumiunix/w/rnaseq">https://usegalaxy.org/u/laiumiunix/w/rnaseq</ext-link>.</p><p id="Par24">A list of all of the lipoprotein receptors was obtained from the Gene Ontology Consortium using the &#x0201c;Lipoprotein particle receptor activity&#x0201d; and &#x0201c;Regulation of plasma lipoprotein particle levels&#x0201d; search terms. The positive controls were marker genes of parietal TGC, whereas the negative controls were markers of TGC from a different lineage that does not give rise to parietal TGC<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>. We considered a gene to be expressed by TGC when the mean read count of that gene was superior to the mean +3 SD of Tpbpa, the negative control with the highest count. This criterion set the threshold at 71 mean reads.</p></sec><sec id="Sec10"><title>Animals</title><p id="Par25">We used mice in a mixed C57Bl6/J &#x000d7;129 background carrying a targeted mutation in the SR-BI locus, generously provided by Monty Krieger (B6;129S2-Scarb1<sup>tm1Kri</sup>/J)<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. Animals were maintained in the animal facility of the Department of Gastroenterology (School of Medicine, Pontificia Universidad Cat&#x000f3;lica de Chile) at 25&#x02009;&#x000b0;C and 12&#x02009;h light:dark cycling and fed standard chow (Prolab RMH3000, Labdiet; 75&#x02009;IU vitamin E/kg) and water <italic>ad libitum</italic>. Protocols were conducted in agreement with the National Research Council (NRC) publication Guide for Care and Use of Laboratory Animals (copyright 1996, National Academy of Science). Studies were approved by the Ethics Committee for Animal Welfare from the School of Medicine of the Pontificia Universidad Cat&#x000f3;lica de Chile.</p><p id="Par26">To generate intercrosses, 2- to 4-month-old heterozygous (SR-BI<sup>+/&#x02212;</sup>) females were caged with 2- to 6-month-old SR-BI<sup>+/&#x02212;</sup> males at a 1:1 or 2:1 ratio. Female mice were checked daily for the presence of a vaginal plug during the first hour of the light cycle. The day a plug was detected was recorded as embryonic day 0.5 (E0.5) and the female was separated from the male and maintained with one or two females in the same cage. All embryos were collected on day E9.5, when neural tube closure is complete in wild-type embryos. Pregnant dams were anaesthetized with a mixture of ketamine:xylazine (0.18&#x02009;mg:0.012&#x02009;mg per gram of body weight) and the peritoneal cavity was exposed. A blood sample was taken from the abdominal vena cava and uteri were excised. Implantation sites were retrieved and the embryos and PYS were collected. Embryos were assessed for neural tube closure and classified into normal or NTD. The visceral yolk sac was snap frozen in liquid nitrogen, preserved at &#x02212;80&#x02009;&#x000b0;C and used for individual genotyping. Embryo and PYS samples were also immediately frozen in liquid nitrogen and stored individually at &#x02212;80&#x02009;&#x000b0;C until use. As each dam produced variable numbers of embryos with different genotypes and phenotypes, pools of embryos retrieved from different dams were used.</p><p id="Par27">For all experiments analysing the impact of vitamin E dietary supplementation, pregnant dams were fed &#x003b1;-tocopherol-enriched chow (Prolab 5P00 diet enriched with 2,000&#x02009;I.U. &#x003b1;-tocopherol/kg, PMI Nutrition International, Richmond, IN) only after mating, from E0.5 to E9.5. Only in the experiment shown in Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>, some of the dams were fed with the vitamin E-enriched diet from E4.5 to E9.5. The diet was kept at &#x02212;20&#x02009;&#x000b0;C until use and stored for no longer than 18 months, and feed in the cages was changed at least every two days. The &#x003b1;-tocopherol-enriched diet contained 1.1 ppm folic acid, which was very similar to the folic acid concentration in the chow diet.</p><p id="Par28">Folic acid (Sigma, MO) in PBS was injected i.p. daily (10&#x02009;mg/kg body weight)<sup><xref ref-type="bibr" rid="CR61">61</xref></sup> to pregnant dams from E0.5 to E9.5. As a control, pregnant dams were injected i.p. with PBS during the same period.</p></sec><sec id="Sec11"><title>Lipoprotein separation</title><p id="Par29">Whole plasma (200&#x02009;&#x000b5;l) was chromatographically fractionated by Fast Protein Liquid Chromatography (FPLC) using a Superose-6 column (GE Life Sciences, PA). The mobile phase was an aqueous solution at pH 7.4 containing 150&#x02009;mM NaCl and 1&#x02009;mM EDTA, at a constant flow of 9&#x02009;ml/hour. The first 15&#x02009;ml was discarded, and then 40 fractions of 300&#x02009;&#x000b5;l each were recovered. To determine the &#x003b1;-tocopherol content of the various lipoprotein classes, the fractions corresponding to each lipoprotein class (as indicated in Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">1B</xref>) were pooled.</p></sec><sec id="Sec12"><title>Cholesterol determination</title><p id="Par30">Cholesterol in whole plasma (10&#x02009;&#x000b5;l) and FPLC fractions (300&#x02009;&#x000b5;l) was measured with the enzymatic method reported by Allain <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>. Samples were incubated for 30&#x02009;minutes at 37&#x02009;&#x000b0;C with reaction buffer (0.5&#x02009;M Tris pH 7.6, 50&#x02009;mM phenol, 50&#x02009;mM 4-chlorophenol, 1% Triton X-100, 0.37% sodium cholate, 0.04% 4-aminoantipyrine, 0.35&#x02009;U/ml cholesterol esterase, 0.1 U/ml cholesterol oxidase, 1.1&#x02009;U/ml peroxidase). The absorbance was measured at 490&#x02009;nm in a plate reader.</p></sec><sec id="Sec13"><title>Vitamin E determination</title><p id="Par31">Pairs of embryos or single PYS were lysed in RIPA buffer containing 1% N-acetylcysteine and centrifuged at 12,000&#x02009;g at 4&#x02009;&#x000b0;C for 10&#x02009;minutes. Lysates, as well as whole plasma (200&#x02009;&#x000b5;l) and pooled FPLC fractions (1.5 to 3&#x02009;ml), were extracted for 1&#x02009;hour in 500&#x02009;&#x000b5;l methanol (0.01% butylated hydroxytoluene) and 5&#x02009;ml hexane. Methanol and hexane mixtures were centrifuged for 5&#x02009;minutes at 1,000&#x02009;g at room temperature, and the supernatants were recovered and dried under nitrogen. Dried extracts were resuspended in methanol:ethanol 1:1 (200&#x02009;&#x000b5;l of mixture) and filtered through a 0.22-&#x000b5;m PTFE filter. The samples were subjected to HPLC through a Symmetry LC-8 reverse phase column (Waters, MA). The mobile phase used was 20&#x02009;mM sodium perchlorate in methanol:water 97.5:2.5 at a constant flux of 1&#x02009;ml/minute controlled by a L-6000 HPLC Pump (Hitachi, IL). Elution signal was detected with a LC-4C amperometric detector (Bioanalytical Systems, Inc., IN) at 600&#x02009;mV vs. Ag/AgCl. The samples were run in triplicate and the signal was interpolated in a standard curve for &#x003b1;-tocopherol. Among the various vitamin E isomers, the only detectable isomer in both PYS and embryos was &#x003b1;-tocopherol.</p></sec><sec id="Sec14"><title>Reactive oxygen species analysis</title><p id="Par32">The presence of reactive oxygen species was detected using the method from Chen<sup><xref ref-type="bibr" rid="CR63">63</xref></sup> with modifications. Pairs of embryos and single parietal yolk sacs were kept on ice and lysed by sonication for 2&#x02009;seconds in 100&#x02009;&#x000b5;l reaction buffer (130&#x02009;mM KCl, 5&#x02009;mM MgCl<sub>2</sub>, 20&#x02009;mM KH<sub>2</sub>PO<sub>4</sub>, 20&#x02009;mM Tris, 30&#x02009;mM glucose). The lysates were incubated with dihydrodichlorofluorescein diacetate (DCF-DA; Sigma, MO) at a final concentration of 50&#x02009;&#x000b5;M, and fluorescence was detected continuously for 1&#x02009;hour at 37&#x02009;&#x000b0;C with an excitation wavelength of 485&#x02009;nm and a detection wavelength of 535&#x02009;nm in a plate reader. For each sample, fluorescence was adjusted based on the protein content. Representative results of this assay for embryos and PYS are shown in Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2</xref>. Negative controls, including lysate-free samples and DCF-DA free samples, showed no fluorescence. As a positive control, lysates were incubated with H<sub>2</sub>O<sub>2</sub> (100&#x02009;&#x000b5;M final concentration) alone or together with N-acetylcysteine (NAC; 0.1% final concentration) just prior to the addition of DCF-DA. Incubation of lysates with H<sub>2</sub>O<sub>2</sub> resulted in a significant increase in fluorescence that was reduced by incubation of lysates with H<sub>2</sub>O<sub>2</sub> and NAC.</p></sec><sec id="Sec15"><title>Sex determination</title><p id="Par33">Individual sexing of embryos was performed by allele discrimination using PCR, as described previously<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>. The primer sequences F: 5&#x02032;-CCGCTGCCAAATTCTTTGG-3&#x02032; and R: 5&#x02032;-TGAAGCTTTTGGCTTTGAG-3&#x02032; were used to amplify the bands corresponding to the smcx and y alleles in the X and Y chromosomes, respectively.</p></sec><sec id="Sec16"><title>Real time PCR</title><p id="Par34">Total RNA was extracted from pools of 3 female embryos and individual parietal yolk sacs using the PureLink RNA Micro Kit (Invitrogen, CA), following the manufacturer&#x02019;s instructions. The embryos used to make the pools came from 9 control litters and 6 vitamin E-supplemented litters. RNA integrity was evaluated using the Bioanalyser 2100 (Agilent, CA) with the Eukaryote Total RNA Nano assay (Agilent, CA). All samples had an RNA Integrity Number of 10. Purified RNA (500 ng) was used for retrotranscription with the iScript RT Supermix (Biorad, CA). The resulting cDNA was amplified by real time PCR with a StepOnePlus thermocycler (Applied Biosystems, CA) using the PowerUp SYBR Green master mix (Thermo, MA) and 100&#x02009;nM of each primer. The primers, annealing temperatures and amplification efficiencies are listed in Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>. All primers were designed using NCBI&#x02019;s Primer-BLAST<sup><xref ref-type="bibr" rid="CR65">65</xref></sup>. The amplification conditions were as follows: 5&#x02009;minutes at 95&#x02009;&#x000b0;C and 40 cycles of 15&#x02009;seconds at 95&#x02009;&#x000b0;C, 15&#x02009;seconds of annealing and 30&#x02009;seconds at 72&#x02009;&#x000b0;C. After every reaction, a melting curve was performed to ensure the amplification of a single product. The amplification efficiency of each pair of primers was determined by serial dilution of a mixture of the cDNAs. Then, the relative expression was calculated for each sample using the equation by Pfaffl<sup><xref ref-type="bibr" rid="CR66">66</xref></sup> (equation 1 in the reference) and the TATA-box binding protein (Tbp) as reference gene.</p></sec><sec id="Sec17"><title>Statistics</title><p id="Par35">Sample sizes were calculated to achieve an 80% power of detecting a 2-fold change with &#x003b1;&#x02009;=&#x02009;0.05. For supplementation with &#x003b1;-tocopherol after implantation, we sought an 80% power to detect a 95% reduction in the presence of NTD in SR-BI<sup>&#x02212;/&#x02212;</sup> embryos with &#x003b1;&#x02009;=&#x02009;0.05.</p><p id="Par36">The assignment of pregnant dams to each treatment group was pseudo-randomized. Each day, the first female with a vaginal plug was assigned to the control group, the second one to one of the treatment groups, and so on. If only one female had a plug one day, the next day the order was reversed. The phenotypic assessments were performed blinded to the genotype of the embryo, but not to the treatment group. Biochemical and real time PCR experiments were performed blind to the genotype and the treatment group of the sample.</p><p id="Par37">Results are shown as scatter plots with a horizontal line indicating the mean (or median where indicated) for arithmetic data, mean&#x02009;&#x000b1;&#x02009;SEM for lipoprotein profiles and geometric mean&#x02009;+&#x02009;error for exponential data obtained from real time PCR experiments. The error represents the uncertainty in estimating the relative expression and is computed using Taylor&#x02019;s series relative to the control group<sup><xref ref-type="bibr" rid="CR67">67</xref></sup>. Therefore, error is reported only for the non-control groups.</p><p id="Par38">The statistical significance of the difference between proportions was evaluated with the Fisher&#x02019;s exact test. Differences between arithmetical means were tested for significance using one-way ANOVA with a Tukey&#x02019;s post-hoc test or two-way ANOVA with the Holms-Sidak post-test. If variances were different between groups, then a non-parametric test was used (Mann-Whitney for two group comparison and Kruskal-Wallis with Dunn&#x02019;s post-test for multigroup comparison). The significance of the difference in gene expression was tested using the Pair-wise Fixed Reallocation Randomization test with the Relative Expression Software Tool<sup><xref ref-type="bibr" rid="CR67">67</xref></sup> Multiple Comparison Solution<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>.</p><p id="Par39">All tests were two-sided, and results were considered significant at p&#x02009;&#x02264;&#x02009;0.05. The statistically significant differences between groups are symbolized by asterisks (*p&#x02009;&#x02264;&#x02009;0.05, **p&#x02009;&#x02264;&#x02009;0.01, ***p&#x02009;&#x02264;&#x02009;0.001).</p></sec></sec><sec sec-type="supplementary-material"><title>Electronic supplementary material</title><sec id="Sec18"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2017_5422_MOESM1_ESM.doc"><caption><p>Supplementary Tables and Figures</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Electronic supplementary material</bold></p><p>
<bold>Supplementary information</bold> accompanies this paper at doi:10.1038/s41598-017-05422-w
</p></fn><fn><p>
<bold>Accession codes:</bold> Hannibal <italic>et al</italic>. generated the RNA dataset used in this study and it is available for download in GEO accession number GSE50585.</p></fn><fn><p>
<bold>Publisher's note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>This study was financed by the Chilean National Council for Scientific and Technological Research (CONICYT) programs Fondo Nacional del Desarrollo Cient&#x000ed;fico y Tecnol&#x000f3;gico (FONDECYT) no. 1141236 (to D.B.), no. 1150399 (to A.R.), no. 1140697 (to V.P.), Ph.D. Fellowship no. 21130444 (to N.S.) and the School of Medicine grant PMD-04/16 (to N.S.). The authors acknowledge Ludwig Amigo for his aid in lipoprotein isolation studies by FPLC and Dr. Pablo Olmos for his generous advice on statistical analyses.</p></ack><notes notes-type="author-contribution"><title>Author Contributions</title><p>N.S. performed most of the experiments reported in this paper and significantly participated in the preparation of the manuscript and figures. M.J.P. performed folate injections for prevention of NTD. A.Q. maintained the SR-BI<sup>+/&#x02212;</sup> mouse colony, genotyped the animals and provided heterozygous SR-BI<sup>+/&#x02212;</sup> males and females for matings. D.P. and G.E. set up and performed vitamin E determinations by HPLC. C.L. extracted raw count data from the RNA-Seq dataset. L.U. and V.P. analysed the expression of the Hh pathway genes in the embryos. A.R. provided the mouse model and participated in the design of experiments and discussion of results. D.B. participated in the generation of hypotheses, design of experiments, discussion of the results and preparation of the final version of the manuscript and figures. All of the contributors reviewed the manuscript and provided their feedback before the final submission.</p></notes><notes notes-type="COI-statement"><sec id="FPar1"><title>Competing Interests</title><p id="Par40">The authors declare that they have no competing interests.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acton</surname><given-names>S</given-names></name><etal/></person-group><article-title>Identification of scavenger receptor SR-BI as a high density lipoprotein receptor</article-title><source>Science</source><year>1996</year><volume>271</volume><fpage>518</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1126/science.271.5248.518</pub-id><?supplied-pmid 8560269?><pub-id pub-id-type="pmid">8560269</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rigotti</surname><given-names>A</given-names></name><name><surname>Miettinen</surname><given-names>HE</given-names></name><name><surname>Krieger</surname><given-names>M</given-names></name></person-group><article-title>The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues</article-title><source>Endocrine reviews</source><year>2003</year><volume>24</volume><fpage>357</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1210/er.2001-0037</pub-id><?supplied-pmid 12788804?><pub-id pub-id-type="pmid">12788804</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rigotti</surname><given-names>A</given-names></name><etal/></person-group><article-title>A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>1997</year><volume>94</volume><fpage>12610</fpage><lpage>12615</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.23.12610</pub-id><?supplied-pmid 9356497?><pub-id pub-id-type="pmid">9356497</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatzopoulos</surname><given-names>AK</given-names></name><name><surname>Rigotti</surname><given-names>A</given-names></name><name><surname>Rosenberg</surname><given-names>RD</given-names></name><name><surname>Krieger</surname><given-names>M</given-names></name></person-group><article-title>Temporal and spatial pattern of expression of the HDL receptor SR-BI during murine embryogenesis</article-title><source>Journal of lipid research</source><year>1998</year><volume>39</volume><fpage>495</fpage><lpage>508</lpage><?supplied-pmid 9548583?><pub-id pub-id-type="pmid">9548583</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santander</surname><given-names>NG</given-names></name><etal/></person-group><article-title>Developmental abnormalities in mouse embryos lacking the HDL receptor SR-BI</article-title><source>Human molecular genetics</source><year>2013</year><volume>22</volume><fpage>1086</fpage><lpage>1096</lpage><pub-id pub-id-type="doi">10.1093/hmg/dds510</pub-id><?supplied-pmid 23221804?><pub-id pub-id-type="pmid">23221804</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindegaard</surname><given-names>ML</given-names></name><etal/></person-group><article-title>Characterization of placental cholesterol transport: ABCA1 is a potential target for in utero therapy of Smith-Lemli-Opitz syndrome</article-title><source>Human molecular genetics</source><year>2008</year><volume>17</volume><fpage>3806</fpage><lpage>3813</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddn278</pub-id><?supplied-pmid 18775956?><pub-id pub-id-type="pmid">18775956</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woollett</surname><given-names>LA</given-names></name></person-group><article-title>Review: Transport of maternal cholesterol to the fetal circulation</article-title><source>Placenta</source><year>2011</year><volume>32</volume><issue>Suppl 2</issue><fpage>S218</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1016/j.placenta.2011.01.011</pub-id><?supplied-pmid 21300403?><pub-id pub-id-type="pmid">21300403</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mardones</surname><given-names>P</given-names></name><etal/></person-group><article-title>Alpha-tocopherol metabolism is abnormal in scavenger receptor class B type I (SR-BI)-deficient mice</article-title><source>The Journal of nutrition</source><year>2002</year><volume>132</volume><fpage>443</fpage><lpage>449</lpage><?supplied-pmid 11880569?><pub-id pub-id-type="pmid">11880569</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>HM</given-names></name><name><surname>Bishop</surname><given-names>KS</given-names></name></person-group><article-title>On the Existence of a Hitherto Unrecognized Dietary Factor Essential for Reproduction</article-title><source>Science</source><year>1922</year><volume>56</volume><fpage>650</fpage><lpage>651</lpage><pub-id pub-id-type="doi">10.1126/science.56.1458.650</pub-id><?supplied-pmid 17838496?><pub-id pub-id-type="pmid">17838496</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Packer</surname><given-names>L</given-names></name><name><surname>Weber</surname><given-names>SU</given-names></name><name><surname>Rimbach</surname><given-names>G</given-names></name></person-group><article-title>Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling</article-title><source>The Journal of nutrition</source><year>2001</year><volume>131</volume><fpage>369S</fpage><lpage>373S</lpage><?supplied-pmid 11160563?><pub-id pub-id-type="pmid">11160563</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rimbach</surname><given-names>G</given-names></name><etal/></person-group><article-title>Regulation of cell signalling by vitamin E</article-title><source>The Proceedings of the Nutrition Society</source><year>2002</year><volume>61</volume><fpage>415</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1079/PNS2002183</pub-id><?supplied-pmid 12691170?><pub-id pub-id-type="pmid">12691170</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>DW</given-names></name><name><surname>Bairnson</surname><given-names>TA</given-names></name><name><surname>Rao</surname><given-names>AN</given-names></name><name><surname>Subbammal</surname><given-names>S</given-names></name></person-group><article-title>Effect of variations of rations on the incidence of teratogeny in vitamin E-deficient rats</article-title><source>The Journal of nutrition</source><year>1960</year><volume>71</volume><fpage>54</fpage><lpage>60</lpage><?supplied-pmid 13809610?><pub-id pub-id-type="pmid">13809610</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>TI</given-names></name><etal/></person-group><article-title>Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects</article-title><source>Diabetologia</source><year>2003</year><volume>46</volume><fpage>538</fpage><lpage>545</lpage><pub-id pub-id-type="doi">10.1007/s00125-003-1063-2</pub-id><?supplied-pmid 12739027?><pub-id pub-id-type="pmid">12739027</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannibal</surname><given-names>RL</given-names></name><etal/></person-group><article-title>Copy number variation is a fundamental aspect of the placental genome</article-title><source>PLoS Genet</source><year>2014</year><volume>10</volume><fpage>e1004290</fpage><pub-id pub-id-type="doi">10.1371/journal.pgen.1004290</pub-id><?supplied-pmid 24785991?><pub-id pub-id-type="pmid">24785991</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watkins</surname><given-names>T</given-names></name><etal/></person-group><article-title>gamma-Tocotrienol as a hypocholesterolemic and antioxidant agent in rats fed atherogenic diets</article-title><source>Lipids</source><year>1993</year><volume>28</volume><fpage>1113</fpage><lpage>1118</lpage><pub-id pub-id-type="doi">10.1007/BF02537079</pub-id><?supplied-pmid 8121254?><pub-id pub-id-type="pmid">8121254</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Busso</surname><given-names>D</given-names></name><etal/></person-group><article-title>Early onset intrauterine growth restriction in a mouse model of gestational hypercholesterolemia and atherosclerosis</article-title><source>BioMed research international</source><year>2014</year><volume>2014</volume><fpage>280497</fpage><pub-id pub-id-type="doi">10.1155/2014/280497</pub-id><?supplied-pmid 25295255?><pub-id pub-id-type="pmid">25295255</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicolosi</surname><given-names>RJ</given-names></name><name><surname>Lawton</surname><given-names>CW</given-names></name><name><surname>Wilson</surname><given-names>TA</given-names></name></person-group><article-title>Vitamin E reduces plasma low density lipoprotein cholesterol, LDL oxidation, and early aortic atherosclerosis compared with black tea in hypercholesterolemic hamsters</article-title><source>Nutrition Research</source><year>1999</year><volume>19</volume><fpage>1201</fpage><lpage>1214</lpage><pub-id pub-id-type="doi">10.1016/S0271-5317(99)00081-0</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bevilacqua</surname><given-names>E</given-names></name><name><surname>Gomes</surname><given-names>SZ</given-names></name><name><surname>Lorenzon</surname><given-names>AR</given-names></name><name><surname>Hoshida</surname><given-names>MS</given-names></name><name><surname>Amarante-Paffaro</surname><given-names>AM</given-names></name></person-group><article-title>NADPH oxidase as an important source of reactive oxygen species at the mouse maternal-fetal interface: putative biological roles</article-title><source>Reproductive biomedicine online</source><year>2012</year><volume>25</volume><fpage>31</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.rbmo.2012.03.016</pub-id><?supplied-pmid 22560120?><pub-id pub-id-type="pmid">22560120</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>St-Pierre</surname><given-names>J</given-names></name><etal/></person-group><article-title>Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators</article-title><source>Cell</source><year>2006</year><volume>127</volume><fpage>397</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.09.024</pub-id><?supplied-pmid 17055439?><pub-id pub-id-type="pmid">17055439</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>MJ</given-names></name><name><surname>Juriloff</surname><given-names>DM</given-names></name></person-group><article-title>An update to the list of mouse mutants with neural tube closure defects and advances toward a complete genetic perspective of neural tube closure</article-title><source>Birth defects research. Part A, Clinical and molecular teratology</source><year>2010</year><volume>88</volume><fpage>653</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.1002/bdra.20676</pub-id><?supplied-pmid 20740593?><pub-id pub-id-type="pmid">20740593</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Copp</surname><given-names>AJ</given-names></name><name><surname>Greene</surname><given-names>ND</given-names></name></person-group><article-title>Neural tube defects&#x02013;disorders of neurulation and related embryonic processes</article-title><source>Wiley interdisciplinary reviews. Developmental biology</source><year>2013</year><volume>2</volume><fpage>213</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1002/wdev.71</pub-id><?supplied-pmid 24009034?><pub-id pub-id-type="pmid">24009034</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Briscoe</surname><given-names>J</given-names></name><name><surname>Small</surname><given-names>S</given-names></name></person-group><article-title>Morphogen rules: design principles of gradient-mediated embryo patterning</article-title><source>Development</source><year>2015</year><volume>142</volume><fpage>3996</fpage><lpage>4009</lpage><pub-id pub-id-type="doi">10.1242/dev.129452</pub-id><?supplied-pmid 26628090?><pub-id pub-id-type="pmid">26628090</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auerbach</surname><given-names>R</given-names></name></person-group><article-title>Analysis of the developmental effects of a lethal mutation in the house mouse</article-title><source>Journal of Experimental Zoology</source><year>1954</year><volume>127</volume><fpage>305</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1002/jez.1401270206</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goulding</surname><given-names>M</given-names></name><etal/></person-group><article-title>Analysis of the Pax-3 gene in the mouse mutant splotch</article-title><source>Genomics</source><year>1993</year><volume>17</volume><fpage>355</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1006/geno.1993.1332</pub-id><?supplied-pmid 8406486?><pub-id pub-id-type="pmid">8406486</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lakhwani</surname><given-names>S</given-names></name><name><surname>Garcia-Sanz</surname><given-names>P</given-names></name><name><surname>Vallejo</surname><given-names>M</given-names></name></person-group><article-title>Alx3-deficient mice exhibit folic acid-resistant craniofacial midline and neural tube closure defects</article-title><source>Developmental biology</source><year>2010</year><volume>344</volume><fpage>869</fpage><lpage>880</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2010.06.002</pub-id><?supplied-pmid 20534379?><pub-id pub-id-type="pmid">20534379</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kur</surname><given-names>E</given-names></name><name><surname>Mecklenburg</surname><given-names>N</given-names></name><name><surname>Cabrera</surname><given-names>RM</given-names></name><name><surname>Willnow</surname><given-names>TE</given-names></name><name><surname>Hammes</surname><given-names>A</given-names></name></person-group><article-title>LRP2 mediates folate uptake in the developing neural tube</article-title><source>Journal of cell science</source><year>2014</year><volume>127</volume><fpage>2261</fpage><lpage>2268</lpage><pub-id pub-id-type="doi">10.1242/jcs.140145</pub-id><?supplied-pmid 24639464?><pub-id pub-id-type="pmid">24639464</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Behringer</surname><given-names>RR</given-names></name><name><surname>de Crombrugghe</surname><given-names>B</given-names></name></person-group><article-title>Prenatal folic acid treatment suppresses acrania and meroanencephaly in mice mutant for the Cart1 homeobox gene</article-title><source>Nature genetics</source><year>1996</year><volume>13</volume><fpage>275</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1038/ng0796-275</pub-id><?supplied-pmid 8673125?><pub-id pub-id-type="pmid">8673125</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>ten Berge</surname><given-names>D</given-names></name><etal/></person-group><article-title>Mouse Alx3: an aristaless-like homeobox gene expressed during embryogenesis in ectomesenchyme and lateral plate mesoderm</article-title><source>Developmental biology</source><year>1998</year><volume>199</volume><fpage>11</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1006/dbio.1998.8921</pub-id><?supplied-pmid 9676189?><pub-id pub-id-type="pmid">9676189</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>DW</given-names></name><name><surname>Chang</surname><given-names>LF</given-names></name><name><surname>Bairnson</surname><given-names>TA</given-names></name></person-group><article-title>Gross observations on developing abnormal embryos induced by maternal vitamin E deficiency</article-title><source>The Anatomical record</source><year>1957</year><volume>129</volume><fpage>167</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1002/ar.1091290204</pub-id><?supplied-pmid 13509190?><pub-id pub-id-type="pmid">13509190</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jishage</surname><given-names>K-i</given-names></name><etal/></person-group><article-title>Vitamin E is essential for mouse placentation but not for embryonic development itself</article-title><source>Biology of reproduction</source><year>2005</year><volume>73</volume><fpage>983</fpage><lpage>987</lpage><pub-id pub-id-type="doi">10.1095/biolreprod.105.043018</pub-id><?supplied-pmid 16014812?><pub-id pub-id-type="pmid">16014812</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raabe</surname><given-names>M</given-names></name><etal/></person-group><article-title>Knockout of the abetalipoproteinemia gene in mice: reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>1998</year><volume>95</volume><fpage>8686</fpage><lpage>8691</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.15.8686</pub-id><?supplied-pmid 9671739?><pub-id pub-id-type="pmid">9671739</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terasawa</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Apolipoprotein B-related gene expression and ultrastructural characteristics of lipoprotein secretion in mouse yolk sac during embryonic development</article-title><source>Journal of lipid research</source><year>1999</year><volume>40</volume><fpage>1967</fpage><lpage>1977</lpage><?supplied-pmid 10553000?><pub-id pub-id-type="pmid">10553000</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Homanics</surname><given-names>GE</given-names></name><etal/></person-group><article-title>Targeted modification of the apolipoprotein B gene results in hypobetalipoproteinemia and developmental abnormalities in mice</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>1993</year><volume>90</volume><fpage>2389</fpage><lpage>2393</lpage><pub-id pub-id-type="doi">10.1073/pnas.90.6.2389</pub-id><?supplied-pmid 8460149?><pub-id pub-id-type="pmid">8460149</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>LS</given-names></name><etal/></person-group><article-title>apo B gene knockout in mice results in embryonic lethality in homozygotes and neural tube defects, male infertility, and reduced HDL cholesterol ester and apo A-I transport rates in heterozygotes</article-title><source>The Journal of clinical investigation</source><year>1995</year><volume>96</volume><fpage>2152</fpage><lpage>2161</lpage><pub-id pub-id-type="doi">10.1172/JCI118269</pub-id><?supplied-pmid 7593600?><pub-id pub-id-type="pmid">7593600</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farese</surname><given-names>RV</given-names><suffix>Jr.</suffix></name><name><surname>Ruland</surname><given-names>SL</given-names></name><name><surname>Flynn</surname><given-names>LM</given-names></name><name><surname>Stokowski</surname><given-names>RP</given-names></name><name><surname>Young</surname><given-names>SG</given-names></name></person-group><article-title>Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>1995</year><volume>92</volume><fpage>1774</fpage><lpage>1778</lpage><pub-id pub-id-type="doi">10.1073/pnas.92.5.1774</pub-id><?supplied-pmid 7878058?><pub-id pub-id-type="pmid">7878058</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farese</surname><given-names>RV</given-names></name><etal/></person-group><article-title>A novel function for apolipoprotein B: lipoprotein synthesis in the yolk sac is critical for maternal-fetal lipid transport in mice</article-title><source>Journal of lipid research</source><year>1996</year><volume>37</volume><fpage>347</fpage><lpage>360</lpage><?supplied-pmid 9026532?><pub-id pub-id-type="pmid">9026532</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Homanics</surname><given-names>GE</given-names></name><etal/></person-group><article-title>Exencephaly and hydrocephaly in mice with targeted modification of the apolipoprotein B (Apob) gene</article-title><source>Teratology</source><year>1995</year><volume>51</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1002/tera.1420510102</pub-id><?supplied-pmid 7597652?><pub-id pub-id-type="pmid">7597652</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greene</surname><given-names>ND</given-names></name><name><surname>Leung</surname><given-names>KY</given-names></name><name><surname>Copp</surname><given-names>AJ</given-names></name></person-group><article-title>Inositol, neural tube closure and the prevention of neural tube defects</article-title><source>Birth defects research</source><year>2017</year><volume>109</volume><fpage>68</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1002/bdra.23533</pub-id><?supplied-pmid 27324558?><pub-id pub-id-type="pmid">27324558</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="other">Wolf, H. T., Hegaard, H. K., Huusom, L. D. &#x00026; Pinborg, A. B. Multivitamin use and adverse birth outcomes in high-income countries: a systematic review and meta-analysis. <italic>American journal of obstetrics and gynecology</italic>, doi:10.1016/j.ajog.2017.03.029 (2017).</mixed-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller-Pinsler</surname><given-names>L</given-names></name><name><surname>Wells</surname><given-names>PG</given-names></name></person-group><article-title>Embryonic catalase protects against ethanol embryopathies in acatalasemic mice and transgenic human catalase-expressing mice in embryo culture</article-title><source>Toxicology and applied pharmacology</source><year>2015</year><volume>287</volume><fpage>232</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1016/j.taap.2015.06.007</pub-id><?supplied-pmid 26074427?><pub-id pub-id-type="pmid">26074427</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nonn</surname><given-names>L</given-names></name><name><surname>Williams</surname><given-names>RR</given-names></name><name><surname>Erickson</surname><given-names>RP</given-names></name><name><surname>Powis</surname><given-names>G</given-names></name></person-group><article-title>The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice</article-title><source>Molecular and cellular biology</source><year>2003</year><volume>23</volume><fpage>916</fpage><lpage>922</lpage><pub-id pub-id-type="doi">10.1128/MCB.23.3.916-922.2003</pub-id><?supplied-pmid 12529397?><pub-id pub-id-type="pmid">12529397</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reece</surname><given-names>EA</given-names></name><name><surname>Wu</surname><given-names>YK</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Dhanasekaran</surname><given-names>D</given-names></name></person-group><article-title>Dietary vitamin and lipid therapy rescues aberrant signaling and apoptosis and prevents hyperglycemia-induced diabetic embryopathy in rats</article-title><source>American journal of obstetrics and gynecology</source><year>2006</year><volume>194</volume><fpage>580</fpage><lpage>585</lpage><pub-id pub-id-type="doi">10.1016/j.ajog.2005.08.052</pub-id><?supplied-pmid 16458664?><pub-id pub-id-type="pmid">16458664</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>AJ</given-names></name><name><surname>Anderson</surname><given-names>D</given-names></name><name><surname>Jenkinson</surname><given-names>PC</given-names></name><name><surname>Parke</surname><given-names>DV</given-names></name></person-group><article-title>The protective effects of L-ascorbic acid and DL-alpha-tocopherol on cultured rat embryos treated with xanthine/xanthine oxidase</article-title><source>Mutation research</source><year>1989</year><volume>214</volume><fpage>137</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/0027-5107(89)90207-8</pub-id><?supplied-pmid 2770759?><pub-id pub-id-type="pmid">2770759</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czyz</surname><given-names>W</given-names></name><name><surname>Morahan</surname><given-names>JM</given-names></name><name><surname>Ebers</surname><given-names>GC</given-names></name><name><surname>Ramagopalan</surname><given-names>SV</given-names></name></person-group><article-title>Genetic, environmental and stochastic factors in monozygotic twin discordance with a focus on epigenetic differences</article-title><source>BMC medicine</source><year>2012</year><volume>10</volume><fpage>93</fpage><pub-id pub-id-type="doi">10.1186/1741-7015-10-93</pub-id><?supplied-pmid 22898292?><pub-id pub-id-type="pmid">22898292</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baranzini</surname><given-names>SE</given-names></name><etal/></person-group><article-title>Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis</article-title><source>Nature</source><year>2010</year><volume>464</volume><fpage>1351</fpage><lpage>1356</lpage><pub-id pub-id-type="doi">10.1038/nature08990</pub-id><?supplied-pmid 20428171?><pub-id pub-id-type="pmid">20428171</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>KI</given-names></name><name><surname>Dy</surname><given-names>C</given-names></name><name><surname>Pugash</surname><given-names>D</given-names></name><name><surname>Williams</surname><given-names>KP</given-names></name></person-group><article-title>Monoamniotic twins discordant for anencephaly managed conservatively with good outcomes: two case reports and a review of the literature</article-title><source>Ultrasound Obstet Gynecol</source><year>2005</year><volume>26</volume><fpage>188</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1002/uog.1947</pub-id><?supplied-pmid 16041680?><pub-id pub-id-type="pmid">16041680</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burga</surname><given-names>A</given-names></name><name><surname>Casanueva</surname><given-names>MO</given-names></name><name><surname>Lehner</surname><given-names>B</given-names></name></person-group><article-title>Predicting mutation outcome from early stochastic variation in genetic interaction partners</article-title><source>Nature</source><year>2011</year><volume>480</volume><fpage>250</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1038/nature10665</pub-id><?supplied-pmid 22158248?><pub-id pub-id-type="pmid">22158248</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vergeer</surname><given-names>M</given-names></name><etal/></person-group><article-title>Genetic variant of the Scavenger Receptor BI in humans</article-title><source>The New England journal of medicine</source><year>2011</year><volume>364</volume><fpage>136</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0907687</pub-id><?supplied-pmid 21226579?><pub-id pub-id-type="pmid">21226579</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zanoni</surname><given-names>P</given-names></name><etal/></person-group><article-title>Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease</article-title><source>Science</source><year>2016</year><volume>351</volume><fpage>1166</fpage><lpage>1171</lpage><pub-id pub-id-type="doi">10.1126/science.aad3517</pub-id><?supplied-pmid 26965621?><pub-id pub-id-type="pmid">26965621</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="other">Rumbold, A., Ota, E., Hori, H., Miyazaki, C. &#x00026; Crowther, C. A. Vitamin E supplementation in pregnancy. <italic>The Cochrane database of systematic reviews</italic>, Cd004069, doi:10.1002/14651858.CD004069.pub3 (2015).</mixed-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandler</surname><given-names>AL</given-names></name><etal/></person-group><article-title>Neural tube defects and maternal intake of micronutrients related to one-carbon metabolism or antioxidant activity. <italic>Birth defects research</italic></article-title><source>Part A, Clinical and molecular teratology</source><year>2012</year><volume>94</volume><fpage>864</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1002/bdra.23068</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilboa</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Maternal intake of vitamin E and birth defects, national birth defects prevention study, 1997 to 2005. <italic>Birth defects research</italic></article-title><source>Part A, Clinical and molecular teratology</source><year>2014</year><volume>100</volume><fpage>647</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1002/bdra.23247</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="other">De-Regil, L. M., Fernandez-Gaxiola, A. C., Dowswell, T. &#x00026; Pena-Rosas, J. P. Effects and safety of periconceptional folate supplementation for preventing birth defects. <italic>The Cochrane database of systematic reviews</italic>, CD007950 (2010).</mixed-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>HY</given-names></name><name><surname>Chen</surname><given-names>HL</given-names></name><name><surname>Feng</surname><given-names>LP</given-names></name></person-group><article-title>Maternal obesity and the risk of neural tube defects in offspring: A meta-analysis</article-title><source>Obesity research &#x00026; clinical practice</source><year>2016</year></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reece</surname><given-names>EA</given-names></name></person-group><article-title>Diabetes-induced birth defects: what do we know? What can we do?</article-title><source>Current diabetes reports</source><year>2012</year><volume>12</volume><fpage>24</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1007/s11892-011-0251-6</pub-id><?supplied-pmid 22167469?><pub-id pub-id-type="pmid">22167469</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HS</given-names></name><etal/></person-group><article-title>Maternal and Neonatal Outcomes in Korean Women with Type 1 and Type 2 Diabetes</article-title><source>Diabetes &#x00026; metabolism journal</source><year>2015</year><volume>39</volume><fpage>316</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.4093/dmj.2015.39.4.316</pub-id><pub-id pub-id-type="pmid">26301193</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blankenberg</surname><given-names>D</given-names></name><etal/></person-group><article-title>Manipulation of FASTQ data with Galaxy</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><fpage>1783</fpage><lpage>1785</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq281</pub-id><?supplied-pmid 20562416?><pub-id pub-id-type="pmid">20562416</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D</given-names></name><etal/></person-group><article-title>TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions</article-title><source>Genome biology</source><year>2013</year><volume>14</volume><fpage>R36</fpage><pub-id pub-id-type="doi">10.1186/gb-2013-14-4-r36</pub-id><?supplied-pmid 23618408?><pub-id pub-id-type="pmid">23618408</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anders</surname><given-names>S</given-names></name><name><surname>Pyl</surname><given-names>PT</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name></person-group><article-title>HTSeq&#x02013;a Python framework to work with high-throughput sequencing data</article-title><source>Bioinformatics</source><year>2015</year><volume>31</volume><fpage>166</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu638</pub-id><?supplied-pmid 25260700?><pub-id pub-id-type="pmid">25260700</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>D</given-names></name><name><surname>Cross</surname><given-names>JC</given-names></name></person-group><article-title>Development and function of trophoblast giant cells in the rodent placenta</article-title><source>The International journal of developmental biology</source><year>2010</year><volume>54</volume><fpage>341</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1387/ijdb.082768dh</pub-id><?supplied-pmid 19876834?><pub-id pub-id-type="pmid">19876834</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burren</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Gene-environment interactions in the causation of neural tube defects: folate deficiency increases susceptibility conferred by loss of Pax3 function</article-title><source>Human molecular genetics</source><year>2008</year><volume>17</volume><fpage>3675</fpage><lpage>3685</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddn262</pub-id><?supplied-pmid 18753144?><pub-id pub-id-type="pmid">18753144</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allain</surname><given-names>CC</given-names></name><name><surname>Poon</surname><given-names>LS</given-names></name><name><surname>Chan</surname><given-names>CSG</given-names></name><name><surname>Richmond</surname><given-names>W</given-names></name><name><surname>Fu</surname><given-names>PC</given-names></name></person-group><article-title>Enzymatic Determination of Total Serum Cholesterol</article-title><source>Clinical Chemistry</source><year>1974</year><volume>20</volume><fpage>470</fpage><lpage>475</lpage><?supplied-pmid 4818200?><pub-id pub-id-type="pmid">4818200</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>SY</given-names></name></person-group><article-title>Analysis of Nrf2-mediated transcriptional induction of antioxidant response in early embryos</article-title><source>Methods in molecular biology</source><year>2012</year><volume>889</volume><fpage>277</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1007/978-1-61779-867-2_17</pub-id><?supplied-pmid 22669671?><pub-id pub-id-type="pmid">22669671</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jim&#x000e9;nez</surname><given-names>A</given-names></name><etal/></person-group><article-title>Experimental demonstration that pre- and post-conceptional mechanisms influence sex ratio in mouse embryos</article-title><source>Molecular reproduction and development</source><year>2003</year><volume>66</volume><fpage>162</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1002/mrd.10345</pub-id><?supplied-pmid 12950103?><pub-id pub-id-type="pmid">12950103</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>J</given-names></name><etal/></person-group><article-title>Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction</article-title><source>BMC bioinformatics</source><year>2012</year><volume>13</volume><fpage>134</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-13-134</pub-id><?supplied-pmid 22708584?><pub-id pub-id-type="pmid">22708584</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaffl</surname><given-names>MW</given-names></name></person-group><article-title>A new mathematical model for relative quantification in real-time RT-PCR</article-title><source>Nucleic acids research</source><year>2001</year><volume>29</volume><fpage>e45</fpage><pub-id pub-id-type="doi">10.1093/nar/29.9.e45</pub-id><?supplied-pmid 11328886?><pub-id pub-id-type="pmid">11328886</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaffl</surname><given-names>MW</given-names></name><name><surname>Horgan</surname><given-names>GW</given-names></name><name><surname>Dempfle</surname><given-names>L</given-names></name></person-group><article-title>Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR</article-title><source>Nucleic acids research</source><year>2002</year><volume>30</volume><fpage>e36</fpage><pub-id pub-id-type="doi">10.1093/nar/30.9.e36</pub-id><?supplied-pmid 11972351?><pub-id pub-id-type="pmid">11972351</pub-id></element-citation></ref></ref-list></back></article>